Isoray, Inc. (ISRY) Company Profile - CorporateInformation.com

Company Search:

Advanced Search

Wright Investors Service Perspectives


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Isoray, Inc. Company Snapshot

Business Description:

Isoray, Inc. operates in the Surgical and medical instruments sector. IsoRay, Inc. (IsoRay) develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. IsoRay International LLC (International) is a wholly owned subsidiary of the Company. IsoRay obtained clearance from the Food and Drug Association for treatment for all solid tumor applications using Cesium-131. Such applications include prostate cancer; ocular melanoma; head, neck and lung tumors; breast cancer; liver cancer; brain cancer; colorectal cancer; gynecological cancer; esophageal cancer, and pancreatic cancer. The seed may be used in surface, interstitial and intracavity applications for tumors with known radio sensitivity. IsoRay has an existing distribution agreement with UralDial LLC (UralDial) that allows UralDial to distribute Proxcelan Cs-131 brachytherapy seeds in Russia. The Company, through UralDial, has regulatory approval to sell Cs-131 seeds in Russia. In our complete report available for purchase the company is compared to: Repro-Med Systems, Inc., Bioject Medical Technologies Inc. and Cytomedix, Inc..

Isoray, Inc.

Stock Performance Chart for Isoray, Inc.

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): .65
(Figures in U.S. Dollars)

1 Week	3.2%		13 Weeks	-5.8%

4 Weeks	-19.8%		52 Weeks	-50.0%

Isoray, Inc. Key Data:

	Ticker:	ISRY	Country:	UNITED STATES

	Exchanges:	ASE	Major Industry:	Drugs, Cosmetics & Health Care

			Sub Industry:	Medical, Surgical & Dental Suppliers

	2011 Sales	5,238,973 (Year Ending Jan 2012).	Employees:	37

	Currency:	U.S. Dollars	Market Cap:	18,837,656

	Fiscal Yr Ends:	June	Shares Outstanding:	28,985,469

	Share Type:	Common	Closely Held Shares:	483,182

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.